136 related articles for article (PubMed ID: 10379039)
1. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models.
Meaney C; O'Driscoll C
Eur J Pharm Sci; 1999 Jul; 8(3):167-75. PubMed ID: 10379039
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model.
Meaney CM; O'Driscoll CM
Int J Pharm; 2000 Oct; 207(1-2):21-30. PubMed ID: 11036226
[TBL] [Abstract][Full Text] [Related]
3. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
4. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
5. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
Berginc K; Trontelj J; Kristl A
Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
[TBL] [Abstract][Full Text] [Related]
6. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
7. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells.
Behrens I; Stenberg P; Artursson P; Kissel T
Pharm Res; 2001 Aug; 18(8):1138-45. PubMed ID: 11587485
[TBL] [Abstract][Full Text] [Related]
8. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes.
Yano K; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
J Pharm Sci; 2010 Mar; 99(3):1336-45. PubMed ID: 19743502
[TBL] [Abstract][Full Text] [Related]
10. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
12. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers.
Mukaizawa F; Taniguchi K; Miyake M; Ogawara K; Odomi M; Higaki K; Kimura T
Int J Pharm; 2009 Feb; 367(1-2):103-8. PubMed ID: 18929635
[TBL] [Abstract][Full Text] [Related]
13. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
14. New and better protocols for a short-term Caco-2 cell culture system.
Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
Johansson F; Hjertberg E; Eirefelt S; Tronde A; Hultkvist Bengtsson U
Eur J Pharm Sci; 2002 Oct; 17(1-2):63-71. PubMed ID: 12356421
[TBL] [Abstract][Full Text] [Related]
16. Interaction of bile salt and phospholipids with bovine submaxillary mucin.
Wiedmann TS; Deye C; Kallick D
Pharm Res; 2001 Jan; 18(1):45-53. PubMed ID: 11336352
[TBL] [Abstract][Full Text] [Related]
17. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
18. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
19. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]